| 1 |
35349716 | PARP inhibitors trap PARP2 and alter the mode of recruitment of PARP2 at DNA damage sites. | 2022 Apr 22 |
2 |
| 2 |
35430559 | Selective degradation of PARP2 by PROTACs via recruiting DCAF16 for triple-negative breast cancer. | 2022 Jun 5 |
1 |
| 3 |
33637776 | BKM120 sensitizes BRCA-proficient triple negative breast cancer cells to olaparib through regulating FOXM1 and Exo1 expression. | 2021 Feb 26 |
1 |
| 4 |
34461785 | Three-component Castagnoli-Cushman reaction with ammonium acetate delivers 2-unsubstituted isoquinol-1-ones as potent inhibitors of poly(ADP-ribose) polymerase (PARP). | 2021 Dec |
1 |
| 5 |
34880209 | FDI-6 inhibits the expression and function of FOXM1 to sensitize BRCA-proficient triple-negative breast cancer cells to Olaparib by regulating cell cycle progression and DNA damage repair. | 2021 Dec 8 |
2 |
| 6 |
32221289 | Differential regulation of breast cancer bone metastasis by PARP1 and PARP2. | 2020 Mar 27 |
2 |
| 7 |
30116283 | Advances in the use of PARP inhibitor therapy for breast cancer. | 2018 |
1 |
| 8 |
29262611 | PARP inhibition causes premature loss of cohesion in cancer cells. | 2017 Nov 28 |
6 |
| 9 |
26931795 | New Targeted Agents in Gynecologic Cancers: Synthetic Lethality, Homologous Recombination Deficiency, and PARP Inhibitors. | 2016 Mar |
1 |
| 10 |
25757679 | Olaparib: an oral PARP-1 and PARP-2 inhibitor with promising activity in ovarian cancer. | 2015 |
4 |
| 11 |
22524618 | The combination of olaparib and camptothecin for effective radiosensitization. | 2012 Apr 23 |
1 |
| 12 |
18800822 | 4-[3-(4-cyclopropanecarbonylpiperazine-1-carbonyl)-4-fluorobenzyl]-2H-phthalazin-1-one: a novel bioavailable inhibitor of poly(ADP-ribose) polymerase-1. | 2008 Oct 23 |
1 |